Literature DB >> 27326035

Type 2 diabetes and cardiovascular diseases: do they share a common soil? The Asian Indian experience.

Rajendra Pradeepa1, Adamsha Nazir1, Viswanathan Mohan1.   

Abstract

In India, diabetes and cardiovascular disease (CVD) are growing health problems. CVD accounts for much of the increased morbidity and premature mortality associated with type 2 diabetes. Moreover, CVD also occurs 2-3 decades earlier among diabetic subjects and runs a more aggressive course and has a worse prognosis. The pathophysiology of the link between diabetes and CVD is complex and multifactorial and understanding the mechanisms of the disease can help identify and treat CVD in patients with diabetes and vice versa. The current article reviews the common antecedents between type 2 diabetes and CVD including non-modifiable and modifiable risk factors and suggests that future research on diabetes and CVD should focus on searching for risk factors for CVD that may be more specific to diabetes, such as hypoglycaemia or medication related comorbidities. Also, the authors recommend research on common genetic variants which might have stronger effects and hence have a potential role in diabetes and CVD risk prediction. Finally, primary prevention trials trying to prevent both diabetes and CVD are the urgent need of the hour!

Entities:  

Keywords:  Endocrinology; coronary artery disease; diabetes; genetics; hypertension; interventional cardiology; pharmacology; valvular disease

Year:  2012        PMID: 27326035      PMCID: PMC4898687          DOI: 10.1136/heartasia-2011-010081

Source DB:  PubMed          Journal:  Heart Asia        ISSN: 1759-1104


  108 in total

Review 1.  Insulin resistance and cardiovascular disease.

Authors:  H N Ginsberg
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study.

Authors:  R M Anjana; R Pradeepa; M Deepa; M Datta; V Sudha; R Unnikrishnan; A Bhansali; S R Joshi; P P Joshi; C S Yajnik; V K Dhandhania; L M Nath; A K Das; P V Rao; S V Madhu; D K Shukla; T Kaur; M Priya; E Nirmal; S J Parvathi; S Subhashini; R Subashini; M K Ali; V Mohan
Journal:  Diabetologia       Date:  2011-09-30       Impact factor: 10.122

3.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

4.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.

Authors:  Katherine Esposito; Alessandro Pontillo; Carmen Di Palo; Giovanni Giugliano; Mariangela Masella; Raffaele Marfella; Dario Giugliano
Journal:  JAMA       Date:  2003-04-09       Impact factor: 56.272

5.  Association of small dense LDL with coronary artery disease and diabetes in urban Asian Indians - the Chennai Urban Rural Epidemiology Study (CURES-8).

Authors:  V Mohan; R Deepa; K Velmurugan; K Gokulakrishnan
Journal:  J Assoc Physicians India       Date:  2005-02

6.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

7.  Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Lars H Lindholm; Hans Ibsen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristiansson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven Snapinn
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

8.  The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics.

Authors:  R J Jarrett; P McCartney; H Keen
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

Review 9.  Diabetes and cardiovascular disease. The "common soil" hypothesis.

Authors:  M P Stern
Journal:  Diabetes       Date:  1995-04       Impact factor: 9.461

10.  Changing patterns of diet, physical activity and obesity among urban, rural and slum populations in north India.

Authors:  K Yadav; A Krishnan
Journal:  Obes Rev       Date:  2008-07-09       Impact factor: 9.213

View more
  2 in total

1.  Subclinical atherosclerosis and silent myocardial ischaemia in patients with type 2 diabetes: a protocol of a clinico-observational study.

Authors:  D S Prasad; Zubair Kabir; K Revathi Devi; A K Dash; B C Das
Journal:  Open Heart       Date:  2014-06-11

2.  Canagliflozin mitigates ferroptosis and ameliorates heart failure in rats with preserved ejection fraction.

Authors:  Sai Ma; Li-Li He; Guo-Rui Zhang; Qing-Juan Zuo; Zhong-Li Wang; Jian-Long Zhai; Ting-Ting Zhang; Yan Wang; Hui-Juan Ma; Yi-Fang Guo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-04-27       Impact factor: 3.195

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.